ClinicalTrials.gov record
Completed Phase 3 Interventional

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

ClinicalTrials.gov ID: NCT04785638

Public ClinicalTrials.gov record NCT04785638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 7:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Open Ventral Hernia Repair, Abdominoplasty, Open Abdominal Hysterectomy, Laparoscopic-assisted Colectomy, and Reduction Mammoplasty

Study identification

NCT ID
NCT04785638
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Innocoll
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • INL-001 (bupivacaine hydrochloride) implant Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 13, 2021
Primary completion
Jan 9, 2023
Completion
Jan 9, 2023
Last update posted
Feb 12, 2023

2021 – 2023

United States locations

U.S. sites
8
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
North Alabama Medical Center Florence Alabama 35630
Helen Keller Hospital Sheffield Alabama 35660
Lotus Clinical Research Pasadena California 91105
Midwest Clinical Research Dayton Ohio 45417
Daneshvari Solanki Houston Texas 77004
Baylor College of Medicine Houston Texas 77030
Memorial Hermann Houston Texas 77089
Endeavor Clinical Trials San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04785638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04785638 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →